128 related articles for article (PubMed ID: 2875157)
1. Diuretic effect of L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, in rats and mice.
Katsube J; Kato T; Katsuyama M; Maeda Y; Nishikawa S; Nakamura M
J Pharm Pharmacol; 1986 Jul; 38(7):533-4. PubMed ID: 2875157
[TBL] [Abstract][Full Text] [Related]
2. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
Morimoto S; Matsumura Y; Ohyama T; Shinyama H; Ichihara T; Takahashi Y; Hisaki K
Jpn J Pharmacol; 1990 Mar; 52(3):431-9. PubMed ID: 2110272
[TBL] [Abstract][Full Text] [Related]
3. DL-threo-DOPS as a precursor of noradrenaline.
Reches A; Jackson-Lewis V; Fahn S
Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
[TBL] [Abstract][Full Text] [Related]
4. Age-related changes in the chronotropic effect and the enzymic decarboxylation of L-threo-3,4-dihydroxphenylserine in the rat heart.
Araki H; Fujiwara H; Tanaka C
J Pharm Pharmacol; 1981 Dec; 33(12):778-82. PubMed ID: 6121849
[TBL] [Abstract][Full Text] [Related]
5. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
Karai N; Kato T; Katsuyama M; Nakamura M; Katsube J
Life Sci; 1987 Jun; 40(23):2261-8. PubMed ID: 3108598
[TBL] [Abstract][Full Text] [Related]
6. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
Sato E; Irie T; Katsube J
Jpn J Pharmacol; 1987 Jan; 43(1):91-3. PubMed ID: 3106684
[TBL] [Abstract][Full Text] [Related]
7. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
[TBL] [Abstract][Full Text] [Related]
8. Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.
Soares-da-Silva P
Gen Pharmacol; 1993 Jan; 24(1):75-81. PubMed ID: 8482506
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
Fujiwara H; Inagaki C; Ikeda Y; Tanaka C
Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060
[TBL] [Abstract][Full Text] [Related]
10. Effects of L-threo-dihydroxyphenylserine on spinal reflexes and decerebrate rigidity in rats.
Ono H; Tanabe M; Nakamura T; Nagano N; Fukuda H
Gen Pharmacol; 1988; 19(3):369-72. PubMed ID: 3138156
[TBL] [Abstract][Full Text] [Related]
11. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
[TBL] [Abstract][Full Text] [Related]
12. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
Kato T; Katsuyama M; Karai N; Nakamura M; Katsube J
Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
[TBL] [Abstract][Full Text] [Related]
13. Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
Suzuki T; Sakoda S; Ueji M; Kishimoto S; Hayashi A; Kondo T; Narabayashi H
Neurology; 1984 Nov; 34(11):1446-50. PubMed ID: 6436731
[TBL] [Abstract][Full Text] [Related]
14. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
Kato T; Karai N; Katsuyama M; Nakamura M; Katsube J
Biochem Pharmacol; 1987 Sep; 36(18):3051-7. PubMed ID: 3115271
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of haloperidol-induced catalepsy by noradrenaline and L-threo-DOPS.
Verhagen-Kamerbeek WD; Hazemeijer I; Korf J; Lakke JP
J Neural Transm Park Dis Dement Sect; 1993; 6(1):17-26. PubMed ID: 8216760
[TBL] [Abstract][Full Text] [Related]
16. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
Semba J; Takahashi R
Psychiatry Res; 1985 Aug; 15(4):319-26. PubMed ID: 3934694
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart.
Ohmura I; Inagaki C; Araki H; Tanaka C
Jpn J Pharmacol; 1978 Oct; 28(5):747-53. PubMed ID: 31501
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].
Yamazaki M; Ikeda Y; Ishikawa M; Inagaki C; Tanaka C
Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992
[TBL] [Abstract][Full Text] [Related]
19. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
[TBL] [Abstract][Full Text] [Related]
20. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) on catecholamine levels in plasma and cerebrospinal fluid (CSF) in anesthetized rats.
Ishikawa Y; Kato Y; Murakami Y; Inoue T; Koshiyama H; Imura H
Proc Soc Exp Biol Med; 1987 Feb; 184(2):197-200. PubMed ID: 3101067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
